(Q34743520)

English

Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

4 August 2017

Future directions in the treatment of neuroendocrine tumors: consensus report of the National Cancer Institute Neuroendocrine Tumor clinical trials planning meeting (English)

1 reference

Europe PubMed Central

4 August 2017

neuroendocrinology

1 reference

based on heuristic

inferred from title

neuroendocrine tumor

1 reference

based on heuristic

inferred from title

Eric Van Cutsem

11

object named as

Eric Van Cutsem

0 references

author name string

Matthew H Kulke

1

1 reference

Europe PubMed Central

4 August 2017

Lillian L Siu

2

1 reference

Europe PubMed Central

4 August 2017

Joel E Tepper

3

1 reference

Europe PubMed Central

4 August 2017

George Fisher

4

1 reference

Europe PubMed Central

4 August 2017

Deborah Jaffe

5

1 reference

Europe PubMed Central

4 August 2017

Daniel G Haller

6

1 reference

Europe PubMed Central

4 August 2017

Lee M Ellis

7

1 reference

Europe PubMed Central

4 August 2017

Jacqueline K Benedetti

8

1 reference

Europe PubMed Central

4 August 2017

Emily K Bergsland

9

1 reference

Europe PubMed Central

4 August 2017

Timothy J Hobday

10

1 reference

Europe PubMed Central

4 August 2017

James Pingpank

12

1 reference

Europe PubMed Central

4 August 2017

Kjell Oberg

13

1 reference

Europe PubMed Central

4 August 2017

Steven J Cohen

14

1 reference

Europe PubMed Central

4 August 2017

Mitchell C Posner

15

1 reference

Europe PubMed Central

4 August 2017

James C Yao

16

1 reference

Europe PubMed Central

4 August 2017

language of work or name

0 references

publication date

24 January 2011

1 reference

Europe PubMed Central

4 August 2017

Journal of Clinical Oncology

1 reference

Europe PubMed Central

4 August 2017

29

1 reference

Europe PubMed Central

4 August 2017

934-943

1 reference

Europe PubMed Central

4 August 2017

7

1 reference

Europe PubMed Central

4 August 2017

90Y-edotreotide for metastatic carcinoid refractory to octreotide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Detecting an overall survival benefit that is derived from progression-free survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Neuroendocrine carcinomas of the lung: a critical analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

O6-methylguanine DNA methyltransferase deficiency and response to temozolomide-based therapy in patients with neuroendocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Blinded independent central review of progression-free survival in phase III clinical trials: important design element or unnecessary expense?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Activity of sunitinib in patients with advanced neuroendocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Proposal for the use of progression-free survival in unblinded randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Endocrine tumours of the gastrointestinal tract. Peptide receptor radionuclide therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Genetics of neuroendocrine and carcinoid tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Hepatic surgery for metastases from neuroendocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

A 5-decade analysis of 13,715 carcinoid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Clinical relevance of MGMT in the treatment of cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Imaging appearances of metastases from neuroendocrine tumours of the pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Somatostatin receptor-mediated imaging and therapy: basic science, current knowledge, limitations and future perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Tumor markers in neuroendocrine tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

7 July 2018

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

26 October 2018

Treatment of metastatic carcinoid tumors with radiolabeled biologic molecules.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

26 October 2018

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

26 October 2018

Assessing the measure of a new drug: is survival the only thing that matters?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

26 October 2018

Targeting vascular endothelial growth factor in advanced carcinoid tumor: a random assignment phase II study of depot octreotide with bevacizumab and pegylated interferon alpha-2b.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

26 October 2018

Development of a disease-specific Quality of Life questionnaire module for patients with gastrointestinal neuroendocrine tumours.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

26 October 2018

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

26 October 2018

Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

26 October 2018

MR imaging of hepatic metastases caused by neuroendocrine tumors: comparing four techniques.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3068065

26 October 2018

Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263089

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263089

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carcinoid tumors: analysis of prognostic factors and survival in 301 patients from a referral center

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263089

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allelic alterations in pancreatic endocrine tumors identified by genome-wide single nucleotide polymorphism analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263089

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Allelic alterations in well-differentiated neuroendocrine tumors (carcinoid tumors) identified by genome-wide single nucleotide polymorphism analysis and comparison with pancreatic endocrine tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263089

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-resolution analysis of genetic alterations in small bowel carcinoid tumors reveals areas of recurrent amplification and loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263089

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report

1 reference

https://pubmed.ncbi.nlm.nih.gov/21263089

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1200/JCO.2010.33.2056

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

1 reference

Europe PubMed Central

4 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34743520&oldid=1977231929"